HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$1.50
Day range
$1.43 - $1.54
Year range
$1.43 - $381.10
Market cap
4.83M USD
Avg Volume
160.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.23M | 3.35% |
Net income | -6.20M | -5.46% |
Net profit margin | — | — |
Earnings per share | -8.40 | 99.32% |
EBITDA | -6.18M | -4.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.41M | 16.66% |
Total assets | 15.62M | 4.71% |
Total liabilities | 9.10M | -12.99% |
Total equity | 6.52M | — |
Shares outstanding | 3.29M | — |
Price to book | 0.74 | — |
Return on assets | -129.89% | — |
Return on capital | -227.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.20M | -5.46% |
Cash from operations | -7.09M | -15.28% |
Cash from investing | — | — |
Cash from financing | 14.36M | 261.90% |
Net change in cash | 7.27M | 432.92% |
Free cash flow | -4.55M | -7.20% |
About
Founded
2016
Headquarters
Website
Employees
37
